Scaling Secure Product Development in Biotech: GRC & Product Security at Accumulus Synergy

Bringing new therapeutics to patients requires not only scientific innovation but world-class cybersecurity. At Accumulus Synergy, Amy Bittle supported the company’s rapid growth by establishing governance, risk, and compliance (GRC) processes and leading enterprise-wide product security oversight.

The Challenge

As a fast-scaling biotech platform, Accumulus Synergy needed clear controls across internal systems, third-party vendors, and product development pipelines. The organization lacked a unified risk posture, and evolving global privacy laws introduced additional complexity.

The Approach

Amy reported directly to the CISO while coordinating risk assessments, control testing, and remediation tracking. She supported vendor due diligence, audit readiness, and enterprise IT compliance. She also led policy development across NIST frameworks while shaping strategy around global data protection regulations.

The Impact

Established scalable security policies supporting global regulatory readiness Improved remediation tracking across GRC controls Supported client audits and reduced response times by 50% Led product security guidance during platform development and vendor integration

The Breakdown: